Results 171 to 180 of about 96,199 (216)
Some of the next articles are maybe not open access.
Allogeneic stem-cell transplantation for renalcellcancer
The Lancet Oncology, 2004Metastatic renal-cell carcinoma (RCC) is resistant to chemotherapy, and patients with this disease have a poor outlook. Immunotherapy by use of cytokines and vaccines against tumour antigens has shown encouraging results in a small group of patients. Advances in the understanding of the graft-versus-tumour effect in haematological malignant disorders ...
Lyndon, Gommersall +5 more
openaire +2 more sources
[Allogeneic stem cell transplantation].
Nihon rinsho. Japanese journal of clinical medicine, 2002Over the last two decades, four major therapeutic approaches have dramatically changed the prognosis in chronic myelogenous leukemia(CML). Those include allogeneic stem cell transplantation, interferon-alpha based regimen, donor-leukocyte infusions, and the revolutionary BCR/ABL tyrosine kinase inhibitor such as STI571.
K, Sawafuji, S, Okamoto
openaire +3 more sources
Allogeneic Stem Cell Transplantation for Multiple Myeloma
Hematology/Oncology Clinics of North America, 2008Prospective trials comparing tandem autologous stem cell transplantation (ASCT) with ASCT followed by allogeneic stem cell transplantation (AlloSCT) have shown mixed results with regard to progression-free and overall survival rates. Thus, AlloSCT, although a potentially curative treatment, is not regarded as a standard treatment for multiple myeloma ...
openaire +2 more sources
[Allogenic stem cell transplantation in the Netherlands].
Nederlands tijdschrift voor geneeskunde, 2009Contains fulltext : 79810.pdf (Publisher’s version ) (Closed access)
Schattenberg, A.V.M.B. +11 more
openaire +2 more sources
Allogeneic Stem Cell Transplantation
2016Allogeneic bone marrow transplantation has emerged as an appropriate treatment for patients with HIV infection and standard indications for allogeneic bone marrow transplantation. The early experience before combination antiretroviral therapy and modern supportive measures was disappointing.
Richard F. Ambinder +2 more
openaire +1 more source
Immunotherapy by Allogeneic Stem Cell Transplantation
2007During the past three decades, allogeneic stem cell transplantation (ASCT) has developed from being an experimental therapy in patients with endstage leukemia into a well-established therapy in patients with a range of disorders of the immunohematopoietic system.
openaire +2 more sources
Transplantation of allogeneic peripheral blood stem cells
Stem Cells, 1995Recombinant G-CSF has been given to over 150 normal donors for the collection of allogeneic or syngeneic peripheral blood stem cells (PBSCs). G-CSF was found to be well-tolerated with mild-moderate bone pain, edema and mild thrombocytopenia being the observed side effects.
W I, Bensinger +5 more
openaire +2 more sources
Nonablative allogeneic hematopoietic stem cell transplantation
Current Opinion in Oncology, 2001During the past few years there has been an explosion of knowledge in nonablative allogeneic stem cell transplantation. This approach to transplantation relies more on the creation of "immunologic space" for engraftment rather than the more traditional approach of creating "physical space" by the application of either intensive radiation or chemical ...
R D, Dansey, R D, Baynes
openaire +2 more sources
Allogeneic Stem Cell Transplantation
2017Allogeneic stem cell transplantation in malignant diseases has evolved as a treatment option for patients with otherwise incurable diseases. The principle of this treatment is a significant tumor reduction by pretransplant chemotherapy or irradiation and immunological consolidation by various effector cells of the adaptive as well as of the innate ...
Patrick Schlegel +3 more
openaire +1 more source
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
Seminars in Hematology, 2008Although it is only used to treat a minority of patients with myelodysplastic syndromes, stem cell transplantation (SCT) is the only proven curative treatment for this condition. Because MDS occurs in a population of older adults with significant comorbidities, reduced-intensity conditioning (RIC) regimens have been particularly important in extending ...
A John, Barrett, Bipin N, Savani
openaire +2 more sources

